Moreover, recent studies have revealed that three common CHEK2 variants, p.Ile157Thr, p.Ser428Phe, and p.Thr476Met, carry a distinctly lower risk of cancer compared to other CHEK2 P/LPs [8]. Here, CHEK2 is linked to cancer.